• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lakeview Urges Quipt's Board to Initiate a Legitimate Review of All Strategic Options Including a Sale, Inclusive of a Credible Bidder's $3.10 All-Cash Offer

    10/22/25 12:10:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email

    Board Should Run a Real Review Process That is Focused on Building – Not Chilling – Acquirer Interest

    Lakeview Opportunity Fund, LLC (together with its affiliates, "we" or "Lakeview Investment Group"), a nearly 5% owner, and top 5 shareholder of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), today expressed its belief that the Company's Board of Directors (the "Board") has undermined the best interests of shareholders by failing to engage in good faith with a credible bidder as part of a transparent and viable strategic review. Rather than open a constructive dialogue with a real bidder and start exploring all avenues to maximize value, the Board has put shareholder value at risk and started to waste Quipt's limited resources on apparent entrenchment efforts, including a clearly frivolous lawsuit. We suspect shareholders are fed up with the Board due to its mishandling of this situation and prior decision to issue itself unjustifiable equity-based compensation.

    We contend the Board needs to finally consider the public facts from the standpoint of independent shareholders:

    Quipt's leadership has overseen enormous value destruction over the past several years.1

     

    1 Year Return

    3 Year

    Annualized

    Return

    5 Year

    Annualized

    Return

    QIPT

    -6.6%

    -13.9%

    -11.1%

    S&P 500

    16.4%

    23.1%

    16.0%

    • Quipt's leadership granted itself restricted stock and options amounting to ~7% of the Company's equity in March 2025 – this followed the Board receiving multiple acquisition proposals from Forager Capital Management. The timing of the grants could lead investors to infer that the Board is more focused on its own interests rather than shareholders' interests.
    • Quipt's directors appear to lack independence based on recent actions, including resorting to pointless litigation against a major shareholder and credible bidder for the Company.
    • A publicly disclosed bidder has submitted a proposal that (i.) represents a significant premium relative to the unaffected price and the current share price, (ii.) does not include a financing contingency, (iii.) does not include requirements for additional diligence and (iv.) conveys an openness to raising the firm's bid.
    • The Company contends that the $3.10 per share offer is "self-serving," and cited recent positive developments at the Company level, however none of these actions have resulted in any tangible returns for shareholders. The only recent news that has driven any positive share price action is when the $3.10 per share bid was publicly announced.
    • Quipt's standalone strategy has failed to generate positive returns and has left shareholders stuck in purgatory, with a subscale Company saddled with significant public company costs, limited institutional investor interest, excluded from any major indices and no clear path towards a turnaround.
    • Quipt has told the market that $3.10 per share significantly undervalues the Company. We agree, and believe a full and transparent strategic review process, focused on a sale, will result in a transaction at a meaningful premium to that price. We urge the Company to do so as soon as possible, and believe it represents by far the best combination of risk and reward for all shareholders.

    If the Board wants to avoid more shareholder criticism and start rebuilding some semblance of trust with the market, it should immediately announce a credible and transparent review supported by new and truly independent advisors.

    Lastly, we urge the Board not to infer certain shareholders' muted reactions to recent events as approval of the directors' conduct. In our view, every single member of the Board will be removed and replaced at the next annual meeting if the status quo persists.

    About Lakeview Investment Group

    Lakeview Opportunity Fund, LLC is a Chicago-based investment manager founded in 2004 with a focus on small- and mid-cap companies. Lakeview's strategy focuses primarily on long-term investments in companies trading at significant discounts to intrinsic value. On select occasions, Lakeview engages directly with company leadership to help drive shareholder value.

    _____________
    1 Bloomberg, data as of 10/21/25.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251022362157/en/

    Lakeview

    Ari Levy / Tim Won, (312) 245-2910

    [email protected] / [email protected]

    Get the next $QIPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wessel Brian Joseph was granted 183,135 shares, increasing direct ownership by 1,297% to 197,260 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:37:03 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas was granted 110,000 shares, increasing direct ownership by 175% to 173,000 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:36:22 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Compliance Officer Miles Mark Alan was granted 110,000 shares (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:35:41 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concerned Shareholder Bradley L. Radoff Urges Quipt Home Medical's Board of Directors to Pursue a Value-Maximizing Sale

    Questions Independent Director Mark Greenberg for His Role in Supporting Substantial Dilution of Shareholders and Rebuffing Inbound Interest Intends to Vote Against Every Incumbent Director at 2026 Annual Meeting if the Board Continues to Put Shareholder Value at Risk Bradley L. Radoff, who collectively with his affiliates owns approximately 4.9% of the outstanding common shares of Quipt Home Medical Corp. (NYSE:QIPT) ("Quipt" or the "Company"), today issued the following statement regarding the manner in which the Company's Board of Directors (the "Board") has failed to capitalize on apparent acquirer interest: "The Board has spent years destroying its credibility by presiding over poor

    12/5/25 4:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Lakeview Urges Quipt's Board to Initiate a Legitimate Review of All Strategic Options Including a Sale, Inclusive of a Credible Bidder's $3.10 All-Cash Offer

    Board Should Run a Real Review Process That is Focused on Building – Not Chilling – Acquirer Interest Lakeview Opportunity Fund, LLC (together with its affiliates, "we" or "Lakeview Investment Group"), a nearly 5% owner, and top 5 shareholder of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), today expressed its belief that the Company's Board of Directors (the "Board") has undermined the best interests of shareholders by failing to engage in good faith with a credible bidder as part of a transparent and viable strategic review. Rather than open a constructive dialogue with a real bidder and start exploring all avenues to maximize value, the Board has put shar

    10/22/25 12:10:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Forager's 120% Premium for Quipt Would Set M&A Benchmark; Board's Inaction Erodes Shareholder IRR

    BIRMINGHAM, Ala., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Forager Capital Management ("Forager"), one of the largest shareholders of Quipt Home Medical Corp. ("Quipt") (NASDAQ:QIPT, TSX:QIPT), with beneficial ownership of 9.7% of the outstanding shares, issued the following statement: "On May 17, 2025 — nearly sixteen weeks ago — Forager submitted an offer to acquire Quipt for $3.10 per share in cash (the "May Offer"). Had Quipt's Board constructively engaged, the transaction could have been completed by now under the timeline outlined in the May Offer. Shareholders would have locked in a 120% return in under six months — a gain that could have already been redeployed into new opport

    9/10/25 8:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    SEC Filings

    View All

    Quipt Home Medical Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quipt Home Medical Corp. (0001540013) (Filer)

    8/27/25 8:15:08 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.

    SCHEDULE 13D/A - Quipt Home Medical Corp. (0001540013) (Subject)

    8/25/25 8:31:47 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Quipt Home Medical Corp. (0001540013) (Filer)

    8/12/25 5:00:58 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Financials

    Live finance-specific insights

    View All

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

    CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a full-service durable medical equipment ("DME") provider, which is wholly owned by Ballad Health (the "Acquiree"). Ballad Health is a prominent integrated health system comprised of 20 hospitals, post-acute care and behavioral health services, and a large multi-specialty group physician practice. Ballad Health serves 29 counties of the Appalachian Highlands in Northeast Tennessee, Southwest Virginia, Northwest North Carolina and Southeast Kentucky. The

    7/7/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care